LSUHSC public health contributes to estimate of HPV-related cancers

November 12, 2008

Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most comprehensive assessment of the burden of human papillomavirus (HPV)-associated cancers in the United States to date. The report, "Assessing the Burden of Human Papillomavirus (HPV)-Associated Cancers in the United States (ABHACUS)," is available now online and will be published in the November 15, 2008 supplement to the journal Cancer.

The publication reports that 25,000 cases of HPV-associated cancers were diagnosed in 38 states and the District of Columbia from 1998-2003. These include cancers of the cervix, vagina, vulva, penis, anus, oral cavity and oropharynx. Human papillomaviruses comprise about 100 different types, more than 30 of which are sexually transmitted. As the data were collected prior to the development of the HPV vaccine, they will provide baseline incidence rates to determine the effectiveness of the vaccine as well as cervical cancer screening programs in reducing the incidence of HPV-associated cancers and precancers.

The most comprehensive analysis studied data from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) cancer registries, including the Louisiana Tumor Registry at LSU Health Sciences Center New Orleans, and the Centers for Disease Control's National Program of Cancer Registries.

The papers on which the LSUHSC public health faculty are co-authors are Incidence of in situ and invasive vulvar cancer in the US, 1998-2003 (p 2865-2872), Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States (p 2873-2882), Understanding the burden of human papillomavirus-associated anal cancers in the US (p 2892-2900), Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003 (p 2901-2909), and Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: The potential role (p 3047-3057).

"The Louisiana Tumor Registry, housed in the LSUHSC School of Public health, has the academic infrastructure and expertise to monitor and evaluate the impact of HPV vaccination on the community," notes Vivien W. Chen, PhD, Director of Louisiana Tumor Registry at LSU Health Sciences Center New Orleans School of Public Health.

"Incidence and mortality rates among African American women in Louisiana are significantly higher than both the rates of Louisiana white women and other African American women in the United States," said Xiao Cheng Wu, MD, MPH, Associate Professor of Public Health and Associate Director of the Louisiana Tumor Registry at LSU Health Sciences Center New Orleans. "This observed black-white disparity can be reduced by equal access to and utilization of HPV vaccination."

"As the Principal Investigator of two CDC funded projects in LA to examine the impact on cancer after introduction of the HPV vaccine I expect we will observe a decrease in HPV related cancers such as cervical and oral cancer," said Edward Peters, DMD, ScD, Assistant Professor of Public Health at LSU Health Sciences Center New Orleans. "For example, about a third of oral cancers are due to HPV infection (the rest due to smoking and drinking) and oral cancers are twice as common in men than women. However, we currently do not vaccinate boys against HPV. We have tremendous opportunity to increase the level of cancer prevention for HPV associated cancers if our current HPV vaccination recommendations expand to include boys and young men ."

Significant findings include:
(Age-adjusted rates are presented in parentheses where appropriate and are per 100,000 persons.)

* CERVIX: More HPV-associated cancers occur in the cervix than any other site - about 10,800 per year. The incidence rate of cervical cancer was 8.9 women during 1998-2003. Black and Hispanic women had higher rates of cervical cancer (12.6 and 14.2, respectively) than white and non-Hispanic women (both 8.4).
* ORAL CAVITY AND OROPHARYNX: Cancers in some areas of the head and neck (oral cavity and oropharynx) are more likely to be HPV-associated than other areas. There were nearly 7,400 potentially HPV-associated cancers of the oral cavity and oropharynx per year - nearly 5,700 among men and about 1,700 among women. Incidence rates for a subset of the HPV-associated cancers of the oral cavity and oropharynx (cancers of the tonsil and cancers of the base of the tongue) were higher in men than women. These cancers significantly increased (3.0 percent) per year during the reporting period.
* ANAL: There were more than 3,000 HPV-associated anal cancers per year - about 1,900 in women and 1,100 in men. HPV-associated anal cancer occurs more frequently among women (1.5) compared to men (1.0). Whites had the highest rates among women (1.6), while blacks had the highest rates among men (1.2).
* VULVAR: There were about 2,300 new cases of vulvar cancer each year during the study period. In contrast to cervical cancer, white women (1.8) had higher rates of vulvar cancer than black (1.3) and Asian/Pacific Islander (0.4) women.
* PENILE: Penile cancer is relatively rare, striking about 800 men each year. Incidence rates were higher among Hispanic men (1.3) than non-Hispanic men (0.8).
* VAGINAL: About 600 women a year developed vaginal cancers. Incidence rates were higher among black women than white women (0.7 and 0.4, respectively), and incidence rates were lowest among Asian/Pacific Islander women (0.3).

Women with a history of cervical cancer have an increased risk of developing subsequent in situ (non-invasive) cancers of the vagina and vulva, as well as invasive cancers of the vagina, vulva, and rectum.

The Cancer supplement chapters also focus on disparities of HPV-associated cancers, how CDC and state and local programs address such disparities, background of the HPV vaccine, the economic impact of HPV-associated cancer mortality, the burden of cervical cancers in specific states with a high burden of disease, and surveillance of behavioral risk factors related to these cancers. The online article is available at: http://www3.interscience.wiley.com/journal/121498429/issue

Louisiana State University Health Sciences Center

---

---

	HPV-related oral cancer incidence spikes.(NEWS): An article from: Skin & Allergy News by Patrice Wendling (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on July 1, 2011. The length of the article is 1120 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: HPV-related oral cancer incidence spikes.(NEWS) Author: Patrice Wendling Publication: Skin & Allergy News (Magazine/Journal) Date: July 1, 2011 Publisher: International Medical News Group Volume: 42 Issue: 7 Page: 4(2) Distributed by Gale, a part of Cengage...
	HPV and Other Infectious Agents in Cancer: Opportunities for Prevention and Public Health by Hans Krueger (Author), Gavin Stuart (Author), Richard Gallagher (Author), Dan Williams (Author), Jon Kerner (Author) After considering the aging population in developed countries, it has become clear to physicians and public policy administrators that prevention of cancer must play a more important role in national anti-cancer policy than it has in the past. The recent introduction of an HPV vaccine, coupled with discoveries concerning the relationship of H. pylori and cancer has brought the role of infectious agents in cancer into sharp focus in the medical community. While interest in the subject has grown, no single source existed to bring clinicians up-to-date on developments in disease mechanisms, population-based risk assessment and policy considerations in the field of cancer prevention. In this current and comprehensive text the authors review the basic science and clinical implications of...
	HPV: Learn About Symptoms, Treatment, Prevention, and More by John Andrews (Author) According to the CDC, human papillomavirus (HPV) is the most common sexually transmitted virus in the United States, and at least 50% of sexually active people will have genital HPV at some time in their lives. This guide will equip you with the facts regarding HPV, including: the signs and symptoms of the virus; the most effective prevention techniques; the available vaccines; information regarding screening tests for cervical cancer; and more. A separate appendix is also included which addresses the health problems caused by HPV in men. Take advantage of this information now and learn to protect yourself and those you care about.
	The production of cervical cancer-related HPV16 E7 oncoprotein in rice seeds. by Amit Mehra (Author) Cervical cancer is a leading cause of cancer-related death in women of developing countries and the second most prevalent cancer among women of developed countries. HR-HPV (high-risk human papillomavirus) type 16 is mainly considered as the causative agent of more than half of clinical cervical cancer cases, and the E7 oncoprotein of HPV16 is responsible for causing and maintaining the transformed state of tumor cells. HPV16 E7 is regarded as a tumor-specific antigen because of continual expression in cancer cells, and hence is a promising target for a therapeutic vaccine against cervical cancer. Since the last decade, plant-based expression systems have been promoted for large-scale production of recombinant proteins of pharmaceutical, industrial and agricultural applications. In this...
	HPV vaccine can prevent early in situ cervical ca: prevents CIN2, CIN3 related to HPV 16, 18.(News): An article from: OB GYN News by Sherry Boschert (Author) This digital document is an article from OB GYN News, published by Thomson Gale on November 1, 2005. The length of the article is 928 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: HPV vaccine can prevent early in situ cervical ca: prevents CIN2, CIN3 related to HPV 16, 18.(News) Author: Sherry Boschert Publication: OB GYN News (Magazine/Journal) Date: November 1, 2005 Publisher: Thomson Gale Volume: 40 Issue: 21 Page: 1(2) Distributed by Thomson...
	Questions & Answers About Human Papilloma Virus (HPV) (100 Questions & Answers about) by Don S. Dizon (Author), Michael L. Krychman (Author) Written by two expert physicians in the field, Questions & Answers About Human Papilloma Virus(HPV) provides authoritative answers to the most commonly asked questions about HPV. This concise guide features current, easy-to-understand information on the virus, related cancers and other diseases, vaccination, and prevention. Also included is a chapter for men diagnosed with the disease. Indispensible reading for parents of adolescent girls, as well as newly diagnosed patients, this essential book dispels common myths about the HPV and gives readers the tools they need to reclaim their health.
	Multidisciplinary Management of Head and Neck Cancer by Robert Haddad MD (Author) Head and neck cancer is a very common cancer worldwide with an estimated 500,000 individuals diagnosed each year. In the United States an average of 39,000 new cases are reported each year representing between 3 to 5% of all new cancer cases diagnosed annually. Head and neck cancers are more common in men and in individuals over the age of 50. The treatment of head and neck cancer is extremely challenging and involves insight and expertise from multiple disciplines. Multidisciplinary Management of Head and Neck Cancer is a comprehensive textbook looking at different aspects of head and neck cancer, including the diagnosis, treatment and outcomes for patients with this disease. The chapters written by world-renowned experts cover the entire discipline of head and neck oncology and include...
	Gardasil: Cervical Cancer Vaccine, Human Papillomavirus (HPV), Related STDs, Authoritative CDC, NIH, and FDA Documents, Clinical References (Essential Guide) by U.S. Government (Author) This up-to-date electronic book on CD-ROM provides the best collection available anywhere of official Federal government information and documents on the subject of the cervical cancer vaccine, Gardasil, along with the Human Papillomavirus (HPV) and related STDs. This CD-ROM uses next-generation search technology that allows complete indexing and makes all files on the disc fully searchable. For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor reference tools and texts have detailed technical information and clinical background material. On June 8, 2006, the Food and Drug Administration (FDA) announced the approval of Gardasil, the first vaccine developed to prevent cervical cancer, precancerous genital...